News Focus
News Focus
icon url

MrLong

03/18/10 1:01 PM

#27789 RE: Myth #27788

So what is this study about: Its scientific team has
isolated five cell populations from the placenta
with the potential to treat a variety of diseases,
based on their anti-inflammatory, angiogenic,
and immunomodulatory properties.

So despite reading: Active Companies in Tissue Engineering & Cell Therapy Stem cell and other pluripotentent cells, biomaterials and other products providing cell- and tissue-based regeneration and therapy

seeing

CorCell listed as one of the 150 along with
Pluristem Therapeutics Inc.,
Osiris Therapeutics Inc

Noting the study has been underway since Nov 2009... You don't believe there's any study? Hmmm, ok.
icon url

MrLong

03/18/10 1:08 PM

#27790 RE: Myth #27788

What if I told you that CorCell is collecting Placenta's right now for Osiris Therapeutics Inc. for research applications today. Would that change your opinion of its involvement in this $6.9B marketplace of cures for the future?

Well, they are doing it! Again, do your own DD and trade accordingly.